GIP and type 2 diabetes mellitus: Counterintuitively, acute administration of exogenous GIP failed to show any effect on energy intake or expenditure, but rather, augmented postprandial glycaemia in patients with T2DM receiving long-acting GLP-1 receptor agonists [98].